Logo Logo
Hilfe
Hilfe
Switch Language to English

Zaienne, Daniel; Willems, Sabine; Schierle, Simone; Heering, Jan und Merk, Daniel (2021): Development and Profiling of Inverse Agonist Tools for the Neuroprotective Transcription Factor Nurr1. In: Journal of Medicinal Chemistry, Bd. 64, Nr. 20: S. 15126-15140

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

The ligand-sensing transcription factor nuclear receptor related 1 (Nurr1) evolves as an appealing target to treat neurodegenerative diseases. Despite its therapeutic potential observed in various rodent models, potent modulators for Nurr1 are lacking as pharmacological tools. Here, we report the structure-activity relationship and systematic optimization of indole-based inverse Nurr1 agonists. Optimized analogues decreased the receptor's intrinsic transcriptional activity by up to more than 90% and revealed preference for inhibiting Nurr1 monomer activity. In orthogonal cell-free settings, we detected displacement of NCoRs and disruption of the Nurr1 homodimer as molecular modes of action. The inverse Nurr1 agonists reduced the expression of Nurr1-regulated genes in T98G cells, and treatment with an inverse Nurr1 agonist mimicked the effect of Nurr1 silencing on interleukin-6 release from LPS-stimulated human astrocytes. The indole-based inverse Nurr1 agonists valuably extend the toolbox of Nurr1 modulators to further probe the role of Nurr1 in neuroinflammation, cancer, and beyond.

Dokument bearbeiten Dokument bearbeiten